
Saturday, March 11, 2023 9:28:46 AM
https://seekingalpha.com/news/3946617-iovance-allogene-and-karyopharm-among-biotechs-with-no-exposure-to-svb
Volume: | - |
Day Range: | |
Bid: | 6.57 |
Ask: | 11.00 |
Last Trade Time: | |
Total Trades: |
Recent KPTI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:13:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:52:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:51:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:49:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:46:17 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/03/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2025 09:16:55 PM
- Karyopharm Announces 1-for-15 Reverse Stock Split • PR Newswire (US) • 02/24/2025 01:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 12:32:17 PM
- Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress • PR Newswire (US) • 02/19/2025 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2025 02:36:58 PM
- Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 • PR Newswire (US) • 02/12/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2025 09:16:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2025 09:15:35 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 02/03/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 09:06:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:34:48 PM
- Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives • PR Newswire (US) • 01/13/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:03:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 10:07:56 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/02/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 12:08:18 PM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM
$PYPD - PolyPid Hits Major Milestone: Completes Trial Enrollment, Poised for Potential Breakthrough in $10 Billion Surgical Infection Market • NRXS • Mar 11, 2025 10:30 AM
UC Asset Acquired $3M Cannabis Property via Non-Cash Deal • UCASU • Mar 11, 2025 9:53 AM
1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting • CBDW • Mar 11, 2025 8:30 AM